Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Guidant Invests $10 Million in Cardiac Device Developer

By HospiMedica staff writers
Posted on 12 Aug 2002
A US$10 million investment has been announced by Guidant Corp. More...
(Indianapolis, IN, USA) in Cardica, Inc. (Menlo Park, CA, USA), a company developing anastomotic devices for coronary bypass surgery.

Anastomosis, the connecting of vein grafts to the aorta and coronary arteries, is a challenging aspect of both traditional bypass surgery and beating heart surgery. Cardica is developing a system to provide surgeons with an easy-to-use, automated method for joining vessels without sewing, dramatically reducing surgery time, allowing for reproducible results, and reducing the likelihood of adverse events.

"We are enthusiastic about the benefits of beating heart surgery to patients, and we anticipate that automated technologies like Cardica's will help speed adoption of this growing procedure and further drive minimally invasive approaches to cardiac surgery,” said Nicky Spaulding, president, cardiac surgery, Guidant.




Related Links:
Guidant
Cardica

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.